HealthEquity Inc (HQY)
Official siteHEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ
Market Cap: $8.56B
Last updated: Nov 17, 2026 at 11:06 AM ET
HealthEquity Inc (HQY) Earnings: Report Dates and Results
HealthEquity (HQY) is confirmed to report earnings on Dec 1, 2026, after the close. In the quarter ended Jul 31, 2026, HealthEquity reported EPS of $1.04, above the $0.99 estimate. It beat the EPS estimate in 7 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
HQY has a confirmed report date of Dec 1, 2026, after the close. Analysts' consensus for the quarter ended Oct 31, 2026 is 13.9% above the $1.01 reported for the quarter ended Oct 31, 2025.
HQY Earnings Call
The latest HQY earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 40 quarters below that had an estimate, HQY beat 33, missed 3 and matched 4. Revenue for the quarter ended Jul 31, 2026 was $350.73M, up 7.6% from $325.83M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 31, 2026 | $1.04 | $0.99 | N/A | +5.05% | Beat | -3.7% | 14 | 2 up, 1 down | Aug 27, 2026 | $350.73M |
| Apr 30, 2026 | $1.07 | $0.94 | N/A | +13.83% | Beat | +10.3% | 15 | 3 up, 4 down | May 28, 2026 | $354.64M |
| Jan 31, 2026 | $0.95 | $0.90 | $0.86 - $0.95 | +5.77% | Beat | +37.7% | 15 | 0 up, 1 down | Mar 17, 2026 | $334.59M |
| Oct 31, 2025 | $1.01 | $0.91 | $0.85 - $0.98 | +10.99% | Beat | +29.5% | 14 | 1 up, 1 down | Dec 3, 2025 | $322.16M |
| Jul 31, 2025 | $1.08 | $0.92 | $0.86 - $1.00 | +17.39% | Beat | +25.6% | 12 | 0 up, 1 down | Sep 2, 2025 | $325.83M |
| Apr 30, 2025 | $0.97 | $0.81 | $0.75 - $0.90 | +19.75% | Beat | +21.2% | 13 | 0 up, 8 down | Jun 3, 2025 | $330.84M |
| Jan 31, 2025 | $0.69 | $0.72 | $0.68 - $0.75 | -4.17% | Miss | +9.5% | 13 | 3 up, 6 down | Mar 18, 2025 | $311.82M |
| Oct 31, 2024 | $0.78 | $0.72 | $0.69 - $0.80 | +8.33% | Beat | +30.0% | 13 | 1 up, 0 down | Dec 9, 2024 | $300.43M |
| Jul 31, 2024 | $0.86 | $0.70 | $0.64 - $0.75 | +22.86% | Beat | +62.3% | 13 | 0 up, 0 down | Sep 3, 2024 | $299.93M |
| Apr 30, 2024 | $0.80 | $0.65 | $0.63 - $0.74 | +23.08% | Beat | +60.0% | 12 | 0 up, 0 down | Jun 3, 2024 | $287.60M |
| Jan 31, 2024 | $0.63 | $0.56 | $0.49 - $0.61 | +12.50% | Beat | +70.3% | 11 | 4 up, 0 down | Mar 19, 2024 | $262.39M |
| Oct 31, 2023 | $0.60 | $0.50 | $0.47 - $0.54 | +20.00% | Beat | +57.9% | 11 | 1 up, 0 down | Dec 5, 2023 | $249.22M |
| Jul 31, 2023 | $0.53 | $0.48 | $0.45 - $0.51 | +10.42% | Beat | +60.6% | 12 | 0 up, 1 down | Sep 5, 2023 | $243.55M |
| Apr 30, 2023 | $0.50 | $0.41 | $0.34 - $0.44 | +21.95% | Beat | +85.2% | 12 | 0 up, 0 down | Jun 5, 2023 | $244.43M |
| Jan 31, 2023 | $0.37 | $0.35 | $0.32 - $0.38 | +5.71% | Beat | +85.0% | 12 | 2 up, 0 down | Mar 21, 2023 | $233.84M |
| Oct 31, 2022 | $0.38 | $0.35 | $0.32 - $0.37 | +8.57% | Beat | +8.6% | 14 | 1 up, 0 down | Dec 6, 2022 | $216.09M |
| Jul 31, 2022 | $0.33 | $0.33 | $0.26 - $0.36 | 0.00% | In line | -17.5% | 11 | 0 up, 0 down | Sep 6, 2022 | $206.14M |
| Apr 30, 2022 | $0.27 | $0.26 | $0.20 - $0.31 | +3.85% | Beat | -28.9% | 8 | 1 up, 0 down | Jun 6, 2022 | $205.68M |
| Jan 31, 2022 | $0.20 | $0.22 | $0.19 - $0.29 | -9.09% | Miss | -52.4% | 10 | 3 up, 1 down | Mar 22, 2022 | $203.30M |
| Oct 31, 2021 | $0.35 | $0.35 | $0.32 - $0.49 | 0.00% | In line | -14.6% | 13 | 1 up, 6 down | Dec 6, 2021 | $179.95M |
| Jul 31, 2021 | $0.40 | $0.36 | $0.32 - $0.48 | +11.11% | Beat | -4.8% | 13 | N/A | Sep 8, 2021 | $189.10M |
| Apr 30, 2021 | $0.38 | $0.32 | $0.28 - $0.39 | +18.75% | Beat | -11.6% | 12 | N/A | Jun 7, 2021 | $184.20M |
| Jan 31, 2021 | $0.42 | $0.40 | $0.29 - $0.44 | +5.00% | Beat | +7.7% | 13 | N/A | Mar 15, 2021 | $188.17M |
| Oct 31, 2020 | $0.41 | $0.36 | $0.31 - $0.41 | +13.89% | Beat | -12.8% | 14 | N/A | Dec 7, 2020 | $179.35M |
| Jul 31, 2020 | $0.42 | $0.28 | $0.25 - $0.30 | +50.00% | Beat | -6.7% | 13 | N/A | Sep 8, 2020 | $176.04M |
| Apr 30, 2020 | $0.43 | $0.44 | $0.33 - $0.50 | -2.27% | Miss | +4.9% | 13 | N/A | Jun 2, 2020 | $190.01M |
| Jan 31, 2020 | $0.39 | $0.36 | $0.21 - $0.43 | +8.33% | Beat | +44.4% | 11 | N/A | Mar 16, 2020 | $201.20M |
| Oct 31, 2019 | $0.47 | $0.23 | $0.15 - $0.26 | +104.35% | Beat | +67.9% | 5 | N/A | Dec 3, 2019 | $157.12M |
| Jul 31, 2019 | $0.45 | $0.35 | $0.32 - $0.36 | +28.57% | Beat | +32.4% | 10 | N/A | Sep 3, 2019 | $86.62M |
| Apr 30, 2019 | $0.41 | $0.34 | $0.32 - $0.35 | +20.59% | Beat | +32.3% | 9 | N/A | Jun 4, 2019 | $87.05M |
| Jan 31, 2019 | $0.27 | $0.22 | $0.16 - $0.25 | +22.73% | Beat | +145.5% | 11 | N/A | Mar 18, 2019 | $75.78M |
| Oct 31, 2018 | $0.28 | $0.25 | $0.23 - $0.28 | +12.00% | Beat | +64.7% | 11 | N/A | Dec 4, 2018 | $70.50M |
| Jul 31, 2018 | $0.34 | $0.28 | $0.25 - $0.30 | +21.43% | Beat | +61.9% | 12 | N/A | Sep 4, 2018 | $71.07M |
| Apr 30, 2018 | $0.31 | $0.28 | $0.25 - $0.29 | +10.71% | Beat | +63.2% | 11 | N/A | Jun 4, 2018 | $69.90M |
| Jan 31, 2018 | $0.11 | $0.09 | $0.07 - $0.11 | +22.22% | Beat | +22.2% | 10 | N/A | Mar 19, 2018 | $60.44M |
| Oct 31, 2017 | $0.17 | $0.16 | N/A | +6.25% | Beat | +41.7% | 10 | N/A | Dec 5, 2017 | $56.79M |
| Jul 31, 2017 | $0.21 | $0.18 | $0.12 - $0.19 | +16.67% | Beat | +31.2% | 10 | N/A | Sep 5, 2017 | $56.88M |
| Apr 30, 2017 | $0.19 | $0.19 | N/A | 0.00% | In line | +26.7% | 10 | N/A | Jun 6, 2017 | $55.42M |
| Jan 31, 2017 | $0.09 | $0.07 | N/A | +28.57% | Beat | +28.6% | N/A | N/A | Mar 21, 2017 | $46.81M |
| Oct 31, 2016 | $0.12 | $0.12 | N/A | 0.00% | In line | +71.4% | N/A | N/A | Dec 6, 2016 | $43.36M |
Annual EPS
EPS for the fiscal year ended Jan 31, 2026 was $4.01, up 28.1% from the year before. It was $0.52 for the year ended Jan 31, 2017, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Jan 31, 2026 | $4.01 | +28.1% |
| Jan 31, 2025 | $3.13 | +38.5% |
| Jan 31, 2024 | $2.26 | +67.4% |
| Jan 31, 2023 | $1.35 | N/A |
| Jan 31, 2022 | $1.33 | -20.8% |
| Jan 31, 2021 | $1.68 | N/A |
| Jan 31, 2020 | $1.72 | +43.3% |
| Jan 31, 2019 | $1.20 | +76.5% |
| Jan 31, 2018 | $0.68 | +30.8% |
| Jan 31, 2017 | $0.52 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 9,000 words across 17 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 8,989 | 17 | |
| 2026Q2 | Jun 30, 2026 | 9,077 | 17 | |
| 2026Q1 | Mar 31, 2026 | 8,884 | 16 | |
| 2025Q4 | Dec 31, 2025 | 5,948 | 15 | |
| 2025Q3 | Sep 30, 2025 | 8,240 | 17 | |
| 2025Q2 | Jun 30, 2025 | 7,009 | 16 | |
| 2025Q1 | Mar 31, 2025 | 6,937 | 15 | |
| 2024Q4 | Dec 31, 2024 | 9,210 | 14 |
2026Q3 Earnings Call
Opening remarks
Richard Putnam Head of Investor Relations Thank you, Dave. Hello, everyone. Thank you for joining us this afternoon. This is HealthEquity's third quarter fiscal year 2026 earnings conference call. My name is Richard Putnam. I do investor relations for HealthEquity. Joining me today are Scott Cutler, President and CEO; Dr. Steve Neeleman, Vice Chair and Founder of the company; and James Lucania, Executive Vice President and CFO. Before I turn the call over to Scott for prepared remarks, we note that a press release announcing our third quarter financial results was issued after the market closed this afternoon. It included certain non-GAAP financial measures that we will reference here today. You can find a copy of today's press release, including reconciliation of these non-GAAP measures with comparable GAAP measures on our Investor Relations website, which is ir.healthequity.com. We also note that our comments and responses today reflect management's views as of today, December 3, 2025, and will contain forward-looking statements as defined by the SEC, including predictions, expectations, estimates, or other information that might be considered forward-looking. There are many important factors relating to our business which could affect our forward-looking statements. These forward-looking statements are subject to risks and uncertainties that may cause our actual results to differ materially from statements made here today. We caution against placing undue reliance on these forward-looking statements. We also encourage you to review the discussion of these factors and other risks that may affect our future results or the market price of our stock, as detailed in our latest annual report on Form 10-K and in subsequent periodic reports filed with the SEC. We assume no obligation to revise or update these forward-looking statements in light of new information or future events. With that out of the way, let's go to Scott.
Scott Cutler President and CEO Thank you, Richard. Happy holidays, and welcome, everyone. I'll start with the key metrics that reflect our continued strong fiscal 2026 results and the progress we're making on our strategy. Steve will then speak to the regulatory environment, and Jim will walk through our third quarter financials and our raised outlook for fiscal year 2026. The team again delivered strong year-over-year growth and margin expansion across our key metrics in Q3, including revenue up 7%, net income up 806% year over year, a result that Jim will explain in more detail in a moment. Adjusted EBITDA up 20% driven by gross margin of 71% and adjusted EBITDA margin of 40%. HSAs grew 6%. CDB accounts up 3%, driving total accounts up 5%, and HSA assets up 15%. Behind these numbers is a clear strategy. Helping our members better save, spend, and invest for health and strengthening the flywheel in each of those areas.
Frequently Asked Questions About HQY
When is HealthEquity's next earnings date?
HealthEquity's next earnings report is confirmed for Dec 1, 2026, after the close.
Did HQY beat earnings estimates last quarter?
Yes. HealthEquity reported EPS of $1.04 for the quarter ended Jul 31, 2026, above the $0.99 estimate, a 5.05% surprise.
What EPS do analysts expect from HQY next quarter?
The consensus EPS estimate for HealthEquity for the quarter ended Oct 31, 2026 is $1.15 from 14 analysts, with estimates from $1.13 to $1.19.
How often does HQY beat earnings estimates?
HealthEquity beat the EPS estimate in 7 of the last 8 quarters, with an average surprise of +9.62%.
Does HQY report before or after the market opens?
HealthEquity is confirmed to report on Dec 1, 2026, after the market closes.
HQY pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts